Markw Kroll News Today

Natixis Investment Managers International increased its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 40.2% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 4,205 shares of the biotechnology company’s stock after acquiring an additional 1,205 shares during the quarter. Natixis Investment Managers International’s holdings in Axon Enterprise were worth […]

GSA Capital Partners LLP acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 6,312 shares of the biotechnology company’s stock, valued at approximately $1,047,000. A number of other large investors […]

UBS Group AG grew its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 65.4% in the 4th quarter, Holdings Channel reports. The fund owned 110,716 shares of the biotechnology company’s stock after buying an additional 43,779 shares during the period. UBS Group AG’s holdings in Axon Enterprise were worth $18,371,000 at […]

Shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) have earned an average rating of “Moderate Buy” from the thirteen research firms that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 […]

Buckley Wealth Management LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,500 shares of the biotechnology company’s stock, valued at approximately $249,000. A number of other hedge funds also recently added […]

JPMorgan Chase & Co. upgraded shares of Axon Enterprise (NASDAQ:AXON – Get Rating) from a neutral rating to an overweight rating in a report published on Thursday, The Fly reports. The brokerage currently has $236.00 price objective on the biotechnology company’s stock. Several other research firms have also commented on AXON. Raymond James lowered Axon […]

Axon Enterprise (NASDAQ:AXON – Get Rating) had its price target boosted by Barclays from $222.00 to $256.00 in a research report sent to investors on Wednesday morning, The Fly reports. Several other equities research analysts also recently issued reports on the company. Needham & Company LLC reiterated a buy rating and issued a $240.00 price […]

Montanaro Asset Management Ltd raised its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 17.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 31,150 shares of the biotechnology company’s stock after buying an additional 4,600 shares during the quarter. […]

Comerica Bank raised its holdings in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 4.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 116,975 shares of the biotechnology company’s stock after buying an additional 5,234 shares during the period. Comerica Bank owned about […]

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.